Mansur RB
Poul Hansen Family Centre for Depression, Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
ArticleKetamine
Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial.
ArticleKetamine
The effect of glutamatergic modulators on sleep behavior and architecture in depressive disorders: A systematic review.
ArticlePsilocybin
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.
ArticleKetamine
A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets.
ArticleKetamine
A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase.
ArticlePsilocybin
Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.
ArticlePsilocybin
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.
ArticleKetamine
Functional Connectivity Between Glutamate Receptor Antagonism and Insulin Pathways: Implications for Modeling Mechanism of Action of Ketamine/Esketamine and Dextromethorphan in Depression Treatment.
ArticleKetamine
A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists.
ArticleKetamine
The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS).
ArticleKetamine
The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
ArticleKetamine
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.
ArticlePsilocybin
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
ArticleKetamine
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
ArticlePsilocybin
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
ArticleKetamine
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
ArticleKetamine
Ketamine for bipolar depression: an updated systematic review.
ArticlePsilocybin
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
ArticlePsilocybin
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
ArticlePsilocybin